C3i Attends the 2025 Cancer Immunotherapy Summit in Toronto

A key moment of networking and collaboration to advance research

C3i was pleased to participate in the Summit for Cancer Immunotherapy, held from April 6 to 8, 2025, in Toronto, a major event organized by BioCanRx. This annual summit brings together researchers, clinicians, patient partners, and industry leaders to discuss progress in cancer immunotherapy and foster collaboration across the field. Many thanks to BioCanRx for the warm welcome and the opening session and to our colleague Julie Artigalas, who proudly represented C3i during the speed intro session. Our representatives, Cynthia Thérien and Julie Artigalas, had the opportunity to meet with several potential partners, discuss current research challenges, and showcase C3i’s expertise to a passionate scientific community.

We left the summit inspired, energized, and proud to contribute to advancing cancer immunotherapy research in Canada.